AIG, Delphi, and More: Billionaire Dan Loeb’s Cheap Stock Picks

Billionaire Dan Loeb is best known for his activist investing, but his fund Third Point simply manages too much capital to be purely focused on activist crusades like Loeb’s recent replacement of Yahoo’s CEO. For example, Third Point’s recent 13F revealed a number of stocks in the fund’s portfolio which are priced very low in terms of their trailing earnings. Naturally, many of these stocks trade at low earnings multiples because they are out of favor with the market or aren’t seen to have good business prospects. And of course investors can’t buy every cheap stock that any of a large number of billionaire investors likes. Still, we think that they make a good starting point for further review. Here are five stocks that Third Point owned at the end of September (see the full list of stocks from their 13F filing) with trailing and forward P/E multiples of 10 or lower:

THIRD POINT

Loeb and his team had initiated a position of 2.3 million shares in American International Group, Inc. (NYSE:AIG) during the second quarter, and between July and September they increased their stake further to a total of 23.5 million shares. AIG was a hot stock in the hedge fund community during the quarter: it grabbed the #3 spot on our list of the most popular stocks among hedge funds (see the full rankings) despite not even being in the top ten at the end of June. Trading at about half the book value of its equity, and at 10 times analyst consensus for 2013, we think that it is a value stock and has plenty of room to rise in price even if it slightly underperforms expectations.

Delphi Automotive PLC (NYSE:DLPH) was another low-multiple stock in Third Point’s portfolio. The $11 billion auto parts company, whose products include electrical, powertrain, and safety systems, carries trailing and forward P/E multiples of 9 and 8, respectively. The entire auto ecosystem- including the carmakers themselves as well as auto parts suppliers- is trading cheaply as the market expects weak macro going forward, particularly in Europe. With Delphi reporting flat earnings in the third quarter compared to the same period in 2011, it seems to be doing fine for now and so it might be a good value.

Third Point owned 2 million shares of UnitedHealth Group Inc. (NYSE:UNH), which recently joined the Dow Jones Industrial Average to represent the health insurance industry. In addition to trading at 10 times earnings, UnitedHealth can boast a fairly low correlation with the broader market (it beta is 0.5) and good growth last quarter (its earnings, for example, rose 23% versus a year earlier). The biggest concern in our minds is uncertainty regarding future regulation of the insurance industry and the healthcare sector more generally, but UnitedHealth is certainly worth considering as a value stock.

WellPoint, Inc. (NYSE:WLP), where Loeb increased his stake 47% to nearly 1.3 million shares is an even cheaper health insurer; it trades at 7 times earnings, whether we consider its historical results in the last four quarters or analyst estimates for next year. However, its business has been about flat and the stock price has fallen 22% in the last year, as the market has perceived it to be underperforming its peers. Again, we’d be very interested in looking more closely at the company though we’re not sure we’d call it a better buy than the fast-growing UnitedHealth.

Another health insurer that Third Point owned was CIGNA Corporation (NYSE:CI), which billionaire David Einhorn of Greenlight Capital had recommended as one of his long picks at the Value Investing Congress in October (check out why Einhorn liked Cigna). Like the other health insurers, Cigna would normally be considered a value stock at 10 times trailing earnings, and with the company expected to grow its business further in 2013 the forward P/E is only 8. Those growth projections are partly derived from a recent acquisition, suggesting that the company won’t need much organic growth to hit the target. We have quite a bit of respect for Einhorn as well as Loeb and with the stock looking cheap we’d be leaning toward Cigna at the moment, though any of the insurers could prove a good value barring extremely punishing regulations.

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Largest Pharmaceutical Companies In the World

The 10 Most Expensive Android Apps

The 9 Most Expensive Designer Bags in the World

The 7 Most Expensive Real Estate in the World

The 10 Most Expensive eBay Items Ever Sold

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!